Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA1c (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trial [0.03%]
针对HbA1c升高的1型糖尿病儿童和成人使用无管床旁自动化胰岛素输注治疗与多次皮下注射治疗的对照性国际多中心平行分组开放随机试验（RADIANT研究）
Emma G Wilmot,Jacques Beltrand,Bruno Guerci et al.
Emma G Wilmot et al.
Background: Automated insulin delivery (AID) systems have been shown to improve glycaemic outcomes in people with type 1 diabetes managed with insulin pump therapy. No randomised studies have evaluated the benefits of tub...
Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study [0.03%]
依拉曲坦治疗库欣综合征患者有效性和安全性的疗效：一项多中心、三期、双盲、安慰剂对照的随机撤药试验（GRACE）研究
Rosario Pivonello,Giorgio Arnaldi,Richard J Auchus et al.
Rosario Pivonello et al.
Background: Relacorilant is a selective glucocorticoid receptor modulator designed to reduce excess cortisol activity by competing with cortisol for glucocorticoid receptor binding, mitigating the clinical manifestations ...
Diabetes and mental health [0.03%]
糖尿病与心理健康
François Pouwer,Dominic Ehrmann,Ragnhild Bjarkøy Strandberg et al.
François Pouwer et al.
This Review summarises the research into five common mental health problems that can affect adults living with type 1 diabetes, type 2 diabetes, or gestational diabetes: fear of hypoglycaemia, diabetes distress, depression, disordered eatin...
Ashley Grossman
Ashley Grossman
Prioritising nutrition alongside paediatric obesity management medications [0.03%]
与儿童肥胖症管理药物并重的营养优先级问题
Cara F Ruggiero,Marie Spreckley,Nikki Davis et al.
Cara F Ruggiero et al.
The Lancet Diabetes Endocrinology
The Lancet Diabetes Endocrinology
3 months vs 12 months of romosozumab for postmenopausal osteoporosis (LIDA): an open-label, non-inferiority, randomised controlled trial [0.03%]
瑞莫杜珠单抗治疗绝经后妇女骨质疏松症的三期临床试验（LIDA）：一项开放性、非劣效性随机对照试验
Benjamin Z Leder,Sabashini K Ramchand,Mackenzie Jordan et al.
Benjamin Z Leder et al.
Background: Postmenopausal osteoporosis is a highly prevalent disease associated with substantial morbidity and mortality. The most recently introduced osteoporosis medication is romosozumab, a monoclonal antibody with a ...
Country-level implementation of Europe's Safe Hearts Plan for cardiovascular health [0.03%]
欧洲心脏安全计划在国家层面的实施以改善心血管健康状况
Stefano Del Prato,Francesco Giorgino,Bart Torbeyns et al.
Stefano Del Prato et al.